Takeda is commited to striving toward better health for patients worldwide through leading innovation in medicine.
|
Product Monograph |
ACTOS®
(pioglitazone hydrochloride)
x Dear Health Care Professional Letter
x Public Communication |
x |
ALVESCO®
(ciclesonide inhalation aerosol) |
x |
DAXAS®
(roflumilast film-coated tablets)
x Prescribing Information
x Patient Brochure |
x |
DEXILANT™
(dexlansoprazole) |
x |
EDARBI™
(azilsartan medoxomil potassium) |
x |
EDARBYCLOR™
(azilsartan medoxomil and chlorthalidone) |
x |
FERAHEME™
(ferumoxytol injection) |
x |
OMNARIS®
(ciclesonide nasal spray) |
x |
ONDISSOLVE™
(ondansetron) |
x |
PANTOLOC®
(pantoprazole sodium) |
x |
Pantoprazole sodium also comes in an intravenous formulation known as PANTO®IV |
x |
TECTA®
pantoprazole magnesium) |
x |
ULORIC®
(febuxostat) |
x |
Partnered Products: |
POLLINEX®-R is the brand name for the medication modified ragweed tyrosine adsorbate vaccine. Registered trademark of Allergy Therapeutics (UK) Ltd. |
x |
Actos® is a registered trademark of Takeda Pharmaceutical Company Limited used under licence by Takeda Canada Inc.
Alvesco®, Daxas®, Omnaris®, Pantoloc®, Panto® IV and Tecta® are registered trademarks of Takeda GmbH. Used under licence.
Dexilant™ is a trademark of Takeda Pharmaceuticals U.S.A., Inc and used under licence by Takeda Canada Inc.
Edarbi™ and Edarbyclor™ are trademarks of Takeda Pharmaceutical Company Limited and used under license by Takeda Canada Inc.
Feraheme™ is a trademark of AMAG Pharmaceuticals, Inc. and used under licence by Takeda Canada Inc.
Ondissolve™ is a trademark of Takeda GmbH. Used under license.
Uloric® is a registered trademark of Teijin Limited and used under licence by Takeda Canada Inc.